ShareholdingMay 7, 2026, 10:21 PM
LifeStance Prices 35M Share Secondary Offering at $8.15; Repurchases 6M
AI Summary
LifeStance Health Group announced the pricing of a secondary underwritten public offering of 35,000,000 shares of its common stock at $8.15 per share by certain selling stockholders. The company will not receive any proceeds from this offering. Concurrently, LifeStance has agreed to repurchase 6,000,000 shares from the underwriter at the same price, conditioned upon the completion of the offering. Both the offering and repurchase are expected to close around May 12, 2026.
Key Highlights
- Secondary offering of 35,000,000 common shares priced at $8.15 per share.
- Total value of the secondary offering is approximately $285.25 million.
- Selling Stockholders will receive all proceeds; LifeStance will not receive any.
- LifeStance to repurchase 6,000,000 shares from the underwriter.
- Repurchase price per share is $8.15, totaling approximately $48.9 million.
- Offering and repurchase expected to settle and close on May 12, 2026.
- J.P. Morgan is acting as the underwriter for the offering.
Price Impact
More from LFST